Literature DB >> 3017546

Inhibition of mitochondrial protein synthesis leads to proliferation arrest in the G1-phase of the cell cycle.

C van den Bogert, G van Kernebeek, L de Leij, A M Kroon.   

Abstract

Mitochondrial protein synthesis is specifically inhibited by low concentrations of tetracyclines. Prolonged inhibition of mitochondrial protein synthesis leads to a lack of oxidative ATP generating capacity, which results in proliferation arrest of normal and malignant cells of epithelial origin, as has been shown previously. The present study indicates that this holds true also for fibroblasts and sarcoma cells. It is shown that this proliferation arrest leads to accumulation of the growth-arrested cells in the G1-phase of the cell cycle. This offers several interesting possibilities to use tetracyclines in anticancer combination therapies.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3017546     DOI: 10.1016/0304-3835(86)90037-6

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  16 in total

Review 1.  Mitochondrial ribosomes in cancer.

Authors:  Hyun-Jung Kim; Priyanka Maiti; Antoni Barrientos
Journal:  Semin Cancer Biol       Date:  2017-04-23       Impact factor: 15.707

2.  Mitochondrial DNA polymerase editing mutation, PolgD257A, disturbs stem-progenitor cell cycling in the small intestine and restricts excess fat absorption.

Authors:  Raymond G Fox; Scott Magness; Gregory C Kujoth; Tomas A Prolla; Nobuyo Maeda
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-02-16       Impact factor: 4.052

3.  Glutathione reductase and a mitochondrial thioredoxin play overlapping roles in maintaining iron-sulfur enzymes in fission yeast.

Authors:  Ji-Yoon Song; Joonseok Cha; Joon Lee; Jung-Hye Roe
Journal:  Eukaryot Cell       Date:  2006-09-01

4.  Local delivery of minocycline and systemic BCNU have synergistic activity in the treatment of intracranial glioma.

Authors:  James L Frazier; Paul P Wang; Daniel Case; Betty M Tyler; Gustavo Pradilla; Jon D Weingart; Henry Brem
Journal:  J Neurooncol       Date:  2003-09       Impact factor: 4.130

5.  Mitochondrial DNA depletion induces radioresistance by suppressing G2 checkpoint activation in human pancreatic cancer cells.

Authors:  Carla R Cloos; David H Daniels; Amanda Kalen; Katee Matthews; Juan Du; Prabhat C Goswami; Joseph J Cullen
Journal:  Radiat Res       Date:  2009-05       Impact factor: 2.841

6.  1-beta-D-arabinofuranosylcytosine (Ara-C) enhances mitochondrial activities in human leukaemic cells.

Authors:  P Muus; C Van den Bogert; H De Vries; A Pennings; M Holtrop; C Haanen
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

7.  Effect of zoledronic acid on the doxycycline-induced decrease in tumour burden in a bone metastasis model of human breast cancer.

Authors:  W C M Duivenvoorden; S Vukmirović-Popović; M Kalina; E Seidlitz; G Singh
Journal:  Br J Cancer       Date:  2007-04-17       Impact factor: 7.640

8.  Doxycycline inhibits leukemic cell migration via inhibition of matrix metalloproteinases and phosphorylation of focal adhesion kinase.

Authors:  Chunhuai Wang; Ru Xiang; Xiangzhong Zhang; Yunxian Chen
Journal:  Mol Med Rep       Date:  2015-05-25       Impact factor: 2.952

9.  Organometallic Iridium(III) anticancer complexes with new mechanisms of action: NCI-60 screening, mitochondrial targeting, and apoptosis.

Authors:  Jessica M Hearn; Isolda Romero-Canelón; Bushra Qamar; Zhe Liu; Ian Hands-Portman; Peter J Sadler
Journal:  ACS Chem Biol       Date:  2013-04-25       Impact factor: 5.100

10.  Dimethylthiourea inhibition of B16 melanoma growth and induction of phenotypic alterations; relationship to ATP levels.

Authors:  A Fux; Y Sidi; G Kessler-Icekson; L Wasserman; A Novogrodsky; J Nordenberg
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.